{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T02:02:13Z","timestamp":1793239333051,"version":"4.5.0"},"reference-count":125,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T00:00:00Z","timestamp":1654128000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T00:00:00Z","timestamp":1654128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["T996-B30"],"award-info":[{"award-number":["T996-B30"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Autoimmune diseases caused by pathogenic IgG4 subclass autoantibodies (IgG4-AID) include diseases like MuSK myasthenia gravis, pemphigus vulgaris or thrombotic thrombocytopenic purpura. Their etiology is still unknown. Polymorphisms in the human leukocyte antigen (HLA) gene locus, particularly in\n                    <jats:italic>HLA-DRB1<\/jats:italic>\n                    , are known genetic susceptibility factors for autoimmune diseases. We hypothesized a similar role for HLA polymorphisms in IgG4-AID and conducted a systematic review and meta-analysis with case\u2013control studies on IgG4-AID based on MOOSE\/ HuGENet guidelines. Genotype (G) and allele (A) frequencies of\n                    <jats:italic>HLA-DQB1*05<\/jats:italic>\n                    (G: OR 3.8; 95% CI 2.44\u20135.9;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.00001; A: OR 2.54; 95% CI 1.82\u20133.55;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.00001) and\n                    <jats:italic>HLA-DRB1*14<\/jats:italic>\n                    (G: OR 4.31; 95% CI 2.82\u20136.59;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.00001; A: OR 4.78; 95% CI 3.52\u20136.49;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.00001) and the\n                    <jats:italic>HLA-DRB1*14-DQB1*05<\/jats:italic>\n                    haplotype (OR 6.3; 95% CI 3.28\u201312.09;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.00001\/OR 4.98; 95% CI 3.8\u20136.53;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.00001) were increased while\n                    <jats:italic>HLA-DRB1*13<\/jats:italic>\n                    (G: OR 0.48; 95% CI 0.34\u20130.68;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.0001; A: OR 0.46; 95% CI 0.34\u20130.62;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.00001) was decreased in IgG4-AID patients. In conclusion, the\n                    <jats:italic>HLA-DQB1*05<\/jats:italic>\n                    ,\n                    <jats:italic>HLA-DRB1*14<\/jats:italic>\n                    alleles and the\n                    <jats:italic>HLA-DQB1*05-DRB1*14<\/jats:italic>\n                    haplotype could be genetic risk factors that predispose for the production of pathogenic IgG4 autoantibodies and the\n                    <jats:italic>HLA-DRB1*13<\/jats:italic>\n                    allele may protect from IgG4 autoimmunity.\n                  <\/jats:p>","DOI":"10.1038\/s41598-022-13042-2","type":"journal-article","created":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T10:03:04Z","timestamp":1654164184000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["A systematic review and meta-analysis of HLA\u00a0class\u00a0II associations in patients with IgG4 autoimmunity"],"prefix":"10.1038","volume":"12","author":[{"given":"Anja","family":"Panhuber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Lamorte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakan","family":"Cetin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romana","family":"H\u00f6ftberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid C.","family":"Erber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Frommlet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0567-021X","authenticated-orcid":false,"given":"Inga","family":"Koneczny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,2]]},"reference":[{"key":"13042_CR1","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1111\/ene.12758","volume":"22","author":"MG Huijbers","year":"2015","unstructured":"Huijbers, M. G. et al. The expanding field of IgG4-mediated neurological autoimmune disorders. Eur. J. Neurol. 22, 1151\u20131161. https:\/\/doi.org\/10.1111\/ene.12758 (2015).","journal-title":"Eur. J. Neurol."},{"key":"13042_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/Fimmu.2018.00097","author":"I Koneczny","year":"2018","unstructured":"Koneczny, I. A new classification system for IgG4 autoantibodies. Front. Immunol. https:\/\/doi.org\/10.3389\/Fimmu.2018.00097 (2018).","journal-title":"Front. Immunol."},{"key":"13042_CR3","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1126\/science.1144603","volume":"317","author":"M van der Neut Kolfschoten","year":"2007","unstructured":"van der Neut Kolfschoten, M. et al. Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange. Science 317, 1554\u20131557. https:\/\/doi.org\/10.1126\/science.1144603 (2007).","journal-title":"Science"},{"key":"13042_CR4","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.jmb.2013.10.039","volume":"426","author":"AM Davies","year":"2014","unstructured":"Davies, A. M. et al. Structural determinants of unique properties of human IgG4-Fc. J. Mol. Biol. 426, 630\u2013644. https:\/\/doi.org\/10.1016\/j.jmb.2013.10.039 (2014).","journal-title":"J. Mol. Biol."},{"key":"13042_CR5","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/j.1365-2222.2009.03207.x","volume":"39","author":"RC Aalberse","year":"2009","unstructured":"Aalberse, R. C., Stapel, S. O., Schuurman, J. & Rispens, T. Immunoglobulin G4: an odd antibody. Clin. Exp. Allergy 39, 469\u2013477. https:\/\/doi.org\/10.1111\/j.1365-2222.2009.03207.x (2009).","journal-title":"Clin. Exp. Allergy"},{"key":"13042_CR6","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1055\/s-0036-1584322","volume":"36","author":"LC Lighaam","year":"2016","unstructured":"Lighaam, L. C. & Rispens, T. The immunobiology of immunoglobulin G4. Semin. Liver Dis. 36, 200\u2013215. https:\/\/doi.org\/10.1055\/s-0036-1584322 (2016).","journal-title":"Semin. Liver Dis."},{"key":"13042_CR7","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/0091-6749(83)90503-1","volume":"72","author":"DM Kemeny","year":"1983","unstructured":"Kemeny, D. M., MacKenzie-Mills, M., Harries, M. G., Youlten, L. J. & Lessof, M. H. Antibodies to purified bee venom proteins and peptides II A detailed study of changes in IgE and IgG antibodies to individual bee venom antigens. J. Allergy Clin. Immunol. 72, 376\u2013385 (1983).","journal-title":"J. Allergy Clin. Immunol."},{"key":"13042_CR8","first-page":"150","volume":"18","author":"DM Kemeny","year":"1983","unstructured":"Kemeny, D. M., McKenzie-Mills, M., Harries, M. G., Youlten, L. J. & Lessof, M. H. Changes in the levels of anti-phospholipase A2 and hyaluronidase antibodies during bee venom immunotherapy. Monogr. Allergy 18, 150\u2013152 (1983).","journal-title":"Monogr. Allergy"},{"key":"13042_CR9","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1111\/all.12236","volume":"68","author":"B Subbarayal","year":"2013","unstructured":"Subbarayal, B. et al. Kinetics, cross-reactivity, and specificity of Bet v 1-specific IgG4 antibodies induced by immunotherapy with birch pollen. Allergy 68, 1377\u20131386. https:\/\/doi.org\/10.1111\/all.12236 (2013).","journal-title":"Allergy"},{"key":"13042_CR10","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.4049\/jimmunol.163.5.2944","volume":"163","author":"RJ van Neerven","year":"1999","unstructured":"van Neerven, R. J. et al. Blocking antibodies induced by specific allergy vaccination prevent the activation of CD4+ T cells by inhibiting serum-IgE-facilitated allergen presentation. J. Immunol. 163, 2944\u20132952 (1999).","journal-title":"J. Immunol."},{"key":"13042_CR11","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1159\/000084227","volume":"136","author":"U Bodtger","year":"2005","unstructured":"Bodtger, U. et al. Is immunotherapy-induced birch-pollen-specific IgG4 a marker for decreased allergen-specific sensitivity?. Int. Arch. Allergy Immunol. 136, 340\u2013346. https:\/\/doi.org\/10.1159\/000084227 (2005).","journal-title":"Int. Arch. Allergy Immunol."},{"key":"13042_CR12","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3389\/fimmu.2018.00097","volume":"9","author":"I Koneczny","year":"2018","unstructured":"Koneczny, I. A New Classification System for IgG4 Autoantibodies. Front. Immunol. 9, 97. https:\/\/doi.org\/10.3389\/fimmu.2018.00097 (2018).","journal-title":"Front. Immunol."},{"key":"13042_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102646","author":"I Koneczny","year":"2020","unstructured":"Koneczny, I. Update on IgG4-mediated autoimmune diseases: New insights and new family members. Autoimmun. Rev. https:\/\/doi.org\/10.1016\/j.autrev.2020.102646 (2020).","journal-title":"Autoimmun. Rev."},{"key":"13042_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.785247","volume":"12","author":"V Endmayr","year":"2021","unstructured":"Endmayr, V. et al. Anti-neuronal IgG4 autoimmune diseases and IgG4-related diseases may not be part of the same spectrum: a comparative study. Front. Immunol. 12, 785247. https:\/\/doi.org\/10.3389\/fimmu.2021.785247 (2021).","journal-title":"Front. Immunol."},{"key":"13042_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.605214","author":"I Koneczny","year":"2021","unstructured":"Koneczny, I. et al. Common denominators in the immunobiology of IgG4 autoimmune diseases: what do glomerulonephritis, pemphigus vulgaris, myasthenia gravis, thrombotic thrombocytopenic purpura and autoimmune encephalitis have in common?. Front. Immunol. https:\/\/doi.org\/10.3389\/fimmu.2020.605214 (2021).","journal-title":"Front. Immunol."},{"key":"13042_CR16","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/nyas.13561","volume":"1413","author":"MG Huijbers","year":"2018","unstructured":"Huijbers, M. G., Plomp, J. J., van der Maarel, S. M. & Verschuuren, J. J. IgG4-mediated autoimmune diseases: a niche of antibody-mediated disorders. Ann. N. Y. Acad. Sci. 1413, 92\u2013103. https:\/\/doi.org\/10.1111\/nyas.13561 (2018).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"13042_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.834342","volume":"13","author":"I Koneczny","year":"2022","unstructured":"Koneczny, I. et al. IgG4 autoantibodies in organ-specific autoimmunopathies: reviewing class switching, antibody-producing cells, and specific immunotherapies. Front. Immunol. 13, 834342. https:\/\/doi.org\/10.3389\/fimmu.2022.834342 (2022).","journal-title":"Front. Immunol."},{"key":"13042_CR18","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13059-017-1207-1","volume":"18","author":"V Matzaraki","year":"2017","unstructured":"Matzaraki, V., Kumar, V., Wijmenga, C. & Zhernakova, A. The MHC locus and genetic susceptibility to autoimmune and infectious diseases. Genome Biol. 18, 76. https:\/\/doi.org\/10.1186\/s13059-017-1207-1 (2017).","journal-title":"Genome Biol."},{"key":"13042_CR19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/tan.13429","volume":"93","author":"ML Lokki","year":"2019","unstructured":"Lokki, M. L. & Paakkanen, R. The complexity and diversity of major histocompatibility complex challenge disease association studies. HLA 93, 3\u201315. https:\/\/doi.org\/10.1111\/tan.13429 (2019).","journal-title":"HLA"},{"key":"13042_CR20","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1146\/annurev-immunol-041015-055420","volume":"34","author":"ER Unanue","year":"2016","unstructured":"Unanue, E. R., Turk, V. & Neefjes, J. Variations in MHC class II antigen processing and presentation in health and disease. Annu. Rev. Immunol. 34, 265\u2013297. https:\/\/doi.org\/10.1146\/annurev-immunol-041015-055420 (2016).","journal-title":"Annu. Rev. Immunol."},{"key":"13042_CR21","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3389\/fimmu.2013.00321","volume":"4","author":"S Tsai","year":"2013","unstructured":"Tsai, S. & Santamaria, P. MHC class II polymorphisms, autoreactive T-cells, and autoimmunity. Front. Immunol. 4, 321. https:\/\/doi.org\/10.3389\/fimmu.2013.00321 (2013).","journal-title":"Front. Immunol."},{"key":"13042_CR22","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s12026-016-8817-7","volume":"65","author":"MT Arango","year":"2017","unstructured":"Arango, M. T. et al. HLA-DRB1 the notorious gene in the mosaic of autoimmunity. Immunol. Res. 65, 82\u201398. https:\/\/doi.org\/10.1007\/s12026-016-8817-7 (2017).","journal-title":"Immunol. Res."},{"key":"13042_CR23","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jaut.2015.03.004","volume":"60","author":"I Alvarez","year":"2015","unstructured":"Alvarez, I. et al. Central T cell tolerance: Identification of tissue-restricted autoantigens in the thymus HLA-DR peptidome. J. Autoimmun. 60, 12\u201319. https:\/\/doi.org\/10.1016\/j.jaut.2015.03.004 (2015).","journal-title":"J. Autoimmun."},{"key":"13042_CR24","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2003170117","author":"NN Logunova","year":"2020","unstructured":"Logunova, N. N. et al. MHC-II alleles shape the CDR3 repertoires of conventional and regulatory naive CD4(+) T cells. Proc. Natl. Acad. Sci. U. S. A. https:\/\/doi.org\/10.1073\/pnas.2003170117 (2020).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"13042_CR25","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/nature22329","volume":"545","author":"JD Ooi","year":"2017","unstructured":"Ooi, J. D. et al. Dominant protection from HLA-linked autoimmunity by antigen-specific regulatory T cells. Nature 545, 243\u2013247. https:\/\/doi.org\/10.1038\/nature22329 (2017).","journal-title":"Nature"},{"key":"13042_CR26","doi-asserted-by":"publisher","first-page":"4718","DOI":"10.4049\/jimmunol.174.8.4718","volume":"174","author":"JS Satoguina","year":"2005","unstructured":"Satoguina, J. S., Weyand, E., Larbi, J. & Hoerauf, A. T regulatory-1 cells induce IgG4 production by B cells: role of IL-10. J. Immunol. 174, 4718\u20134726 (2005).","journal-title":"J. Immunol."},{"key":"13042_CR27","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.1002\/eji.200838193","volume":"38","author":"JS Satoguina","year":"2008","unstructured":"Satoguina, J. S. et al. Tr1 and naturally occurring regulatory T cells induce IgG4 in B cells through GITR\/GITR-L interaction, IL-10 and TGF-beta. Eur. J. Immunol. 38, 3101\u20133113. https:\/\/doi.org\/10.1002\/eji.200838193 (2008).","journal-title":"Eur. J. Immunol."},{"key":"13042_CR28","doi-asserted-by":"publisher","first-page":"3730","DOI":"10.1073\/pnas.90.8.3730","volume":"90","author":"J Punnonen","year":"1993","unstructured":"Punnonen, J. et al. Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc. Natl. Acad. Sci. U. S. A. 90, 3730\u20133734 (1993).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"13042_CR29","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.1084\/jem.20080193","volume":"205","author":"F Meiler","year":"2008","unstructured":"Meiler, F. et al. In vivo switch to IL-10-secreting T regulatory cells in high dose allergen exposure. J. Exp. Med. 205, 2887\u20132898. https:\/\/doi.org\/10.1084\/jem.20080193 (2008).","journal-title":"J. Exp. Med."},{"key":"13042_CR30","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1111\/j.1398-9995.2008.01774.x","volume":"63","author":"F Meiler","year":"2008","unstructured":"Meiler, F., Klunker, S., Zimmermann, M., Akdis, C. A. & Akdis, M. Distinct regulation of IgE, IgG4 and IgA by T regulatory cells and toll-like receptors. Allergy 63, 1455\u20131463. https:\/\/doi.org\/10.1111\/j.1398-9995.2008.01774.x (2008).","journal-title":"Allergy"},{"key":"13042_CR31","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.4049\/jimmunol.160.7.3555","volume":"160","author":"P Jeannin","year":"1998","unstructured":"Jeannin, P., Lecoanet, S., Delneste, Y., Gauchat, J. F. & Bonnefoy, J. Y. IgE versus IgG4 production can be differentially regulated by IL-10. J. Immunol. 160, 3555\u20133561 (1998).","journal-title":"J. Immunol."},{"key":"13042_CR32","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1053\/j.gastro.2015.01.041","volume":"148","author":"NL Berntsen","year":"2015","unstructured":"Berntsen, N. L. et al. Association between HLA haplotypes and increased serum levels of IgG4 in patients with primary sclerosing cholangitis. Gastroenterology 148, 924\u2013927. https:\/\/doi.org\/10.1053\/j.gastro.2015.01.041 (2015).","journal-title":"Gastroenterology"},{"key":"13042_CR33","doi-asserted-by":"publisher","DOI":"10.1111\/cei.13302","author":"M Cebi","year":"2019","unstructured":"Cebi, M. et al. Relation of HLA-DRB1 to IgG4 autoantibody and cytokine production in muscle-specific tyrosine kinase myasthenia gravis (MuSK-MG). Clin. Exp. Immunol. https:\/\/doi.org\/10.1111\/cei.13302 (2019).","journal-title":"Clin. Exp. Immunol."},{"key":"13042_CR34","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1006\/cyto.1999.0642","volume":"12","author":"KC Bhol","year":"2000","unstructured":"Bhol, K. C., Rojas, A. I., Khan, I. U. & Ahmed, A. R. Presence of interleukin 10 in the serum and blister fluid of patients with pemphigus vulgaris and pemphigoid. Cytokine 12, 1076\u20131083. https:\/\/doi.org\/10.1006\/cyto.1999.0642 (2000).","journal-title":"Cytokine"},{"key":"13042_CR35","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1080\/08820130902943097","volume":"38","author":"A Satyam","year":"2009","unstructured":"Satyam, A., Khandpur, S., Sharma, V. K. & Sharma, A. Involvement of T(H)1\/T(H)2 cytokines in the pathogenesis of autoimmune skin disease-Pemphigus vulgaris. Immunol. Invest. 38, 498\u2013509 (2009).","journal-title":"Immunol. Invest."},{"key":"13042_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0123546","volume":"10","author":"V Yilmaz","year":"2015","unstructured":"Yilmaz, V. et al. Differential cytokine changes in patients with myasthenia gravis with antibodies against AChR and MuSK. PLoS ONE 10, e0123546. https:\/\/doi.org\/10.1371\/journal.pone.0123546 (2015).","journal-title":"PLoS ONE"},{"key":"13042_CR37","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1111\/bjh.12707","volume":"164","author":"JP Westwood","year":"2014","unstructured":"Westwood, J. P., Langley, K., Heelas, E., Machin, S. J. & Scully, M. Complement and cytokine response in acute Thrombotic Thrombocytopenic Purpura. Br. J. Haematol. 164, 858\u2013866. https:\/\/doi.org\/10.1111\/bjh.12707 (2014).","journal-title":"Br. J. Haematol."},{"key":"13042_CR38","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1084\/jem.178.6.2213","volume":"178","author":"G Aversa","year":"1993","unstructured":"Aversa, G. et al. An interleukin 4 (IL-4) mutant protein inhibits both IL-4 or IL-13-induced human immunoglobulin G4 (IgG4) and IgE synthesis and B cell proliferation: support for a common component shared by IL-4 and IL-13 receptors. J. Exp. Med. 178, 2213\u20132218 (1993).","journal-title":"J. Exp. Med."},{"key":"13042_CR39","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1111\/j.1365-2133.2012.11040.x","volume":"167","author":"L Yan","year":"2012","unstructured":"Yan, L., Wang, J. M. & Zeng, K. Association between HLA-DRB1 polymorphisms and pemphigus vulgaris: a meta-analysis. Br. J. Dermatol. 167, 768\u2013777. https:\/\/doi.org\/10.1111\/j.1365-2133.2012.11040.x (2012).","journal-title":"Br. J. Dermatol."},{"key":"13042_CR40","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/ane.12951","volume":"138","author":"Y Hong","year":"2018","unstructured":"Hong, Y., Li, H. F., Romi, F., Skeie, G. O. & Gilhus, N. E. HLA and MuSK-positive myasthenia gravis: a systemic review and meta-analysis. Acta Neurol. Scand. 138, 219\u2013226. https:\/\/doi.org\/10.1111\/ane.12951 (2018).","journal-title":"Acta Neurol. Scand."},{"key":"13042_CR41","unstructured":"Little J, H. J. e. (Centers for Disease Control and Prevention, Equator network, 2006)."},{"key":"13042_CR42","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","volume":"283","author":"DF Stroup","year":"2000","unstructured":"Stroup, D. F. et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283, 2008\u20132012. https:\/\/doi.org\/10.1001\/jama.283.15.2008 (2000).","journal-title":"JAMA"},{"key":"13042_CR43","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1186\/s12913-014-0579-0","volume":"14","author":"AM Methley","year":"2014","unstructured":"Methley, A. M., Campbell, S., Chew-Graham, C., McNally, R. & Cheraghi-Sohi, S. PICO, PICOS and SPIDER: a comparison study of specificity and sensitivity in three search tools for qualitative systematic reviews. BMC Health Serv. Res. 14, 579. https:\/\/doi.org\/10.1186\/s12913-014-0579-0 (2014).","journal-title":"BMC Health Serv. Res."},{"key":"13042_CR44","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","volume":"5","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani, M., Hammady, H., Fedorowicz, Z. & Elmagarmid, A. Rayyan-a web and mobile app for systematic reviews. Syst. Rev. 5, 210. https:\/\/doi.org\/10.1186\/s13643-016-0384-4 (2016).","journal-title":"Syst. Rev."},{"key":"13042_CR45","doi-asserted-by":"publisher","unstructured":"Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G. & Group, P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J. Clin. Epidemiol. 62, 1006-1012, https:\/\/doi.org\/10.1016\/j.jclinepi.2009.06.005 (2009).","DOI":"10.1016\/j.jclinepi.2009.06.005"},{"key":"13042_CR46","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nprot.2010.182","volume":"6","author":"GM Clarke","year":"2011","unstructured":"Clarke, G. M. et al. Basic statistical analysis in genetic case-control studies. Nat. Protoc. 6, 121\u2013133. https:\/\/doi.org\/10.1038\/nprot.2010.182 (2011).","journal-title":"Nat. Protoc."},{"key":"13042_CR47","doi-asserted-by":"publisher","unstructured":"Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G. & Group, P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 6, e1000097, https:\/\/doi.org\/10.1371\/journal.pmed.1000097 (2009).","DOI":"10.1371\/journal.pmed.1000097"},{"key":"13042_CR48","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1212\/01.wnl.0000339103.08830.86","volume":"72","author":"E Bartoccioni","year":"2009","unstructured":"Bartoccioni, E. et al. HLA class II allele analysis in MuSK-positive myasthenia gravis suggests a role for DQ5. Neurology 72, 195\u2013197. https:\/\/doi.org\/10.1212\/01.wnl.0000339103.08830.86 (2009).","journal-title":"Neurology"},{"key":"13042_CR49","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1080\/08820139.2017.1385622","volume":"47","author":"S Li","year":"2018","unstructured":"Li, S. et al. Association between HLA-DQB1 polymorphisms and pemphigus vulgaris: a meta-analysis. Immunol. Invest. 47, 101\u2013112. https:\/\/doi.org\/10.1080\/08820139.2017.1385622 (2018).","journal-title":"Immunol. Invest."},{"key":"13042_CR50","volume-title":"Clinical Aspects of Immunology","author":"PGH Gell","year":"1963","unstructured":"Gell, P. G. H. & Coombs, R. R. A. Clinical Aspects of Immunology (Blackwell, 1963)."},{"key":"13042_CR51","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S0896-6273(01)00296-3","volume":"30","author":"MET Boyle","year":"2001","unstructured":"Boyle, M. E. T. et al. Contactin orchestrates assembly of the septate-like junctions at the paranode in myelinated peripheral nerve. Neuron 30, 385\u2013397. https:\/\/doi.org\/10.1016\/S0896-6273(01)00296-3 (2001).","journal-title":"Neuron"},{"key":"13042_CR52","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1083\/jcb.150.3.657","volume":"150","author":"S Tait","year":"2000","unstructured":"Tait, S. et al. An oligodendrocyte cell adhesion molecule at the site of assembly of the paranodal axo-glial junction. J. Cell Biol. 150, 657\u2013666. https:\/\/doi.org\/10.1083\/jcb.150.3.657 (2000).","journal-title":"J. Cell Biol."},{"key":"13042_CR53","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13317-019-0124-6","volume":"11","author":"S Muniz-Castrillo","year":"2020","unstructured":"Muniz-Castrillo, S., Vogrig, A. & Honnorat, J. Associations between HLA and autoimmune neurological diseases with autoantibodies. Auto-immun. Highlights 11, 2. https:\/\/doi.org\/10.1186\/s13317-019-0124-6 (2020).","journal-title":"Auto-immun. Highlights"},{"key":"13042_CR54","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.autrev.2010.05.016","volume":"9","author":"A Rojas-Villarraga","year":"2010","unstructured":"Rojas-Villarraga, A., Botello-Corzo, D. & Anaya, J. M. HLA-Class II in Latin American patients with type 1 diabetes. Autoimmun. Rev. 9, 666\u2013673. https:\/\/doi.org\/10.1016\/j.autrev.2010.05.016 (2010).","journal-title":"Autoimmun. Rev."},{"key":"13042_CR55","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1080\/08820139.2018.1493498","volume":"48","author":"A Hajjej","year":"2019","unstructured":"Hajjej, A. et al. Association of HLA-DRB1 and -DQB1 alleles with type 1 (autoimmune) diabetes in African Arabs: systematic review and meta-analysis. Immunol. Invest. 48, 130\u2013146. https:\/\/doi.org\/10.1080\/08820139.2018.1493498 (2019).","journal-title":"Immunol. Invest."},{"key":"13042_CR56","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.autrev.2011.10.002","volume":"11","author":"P Cruz-Tapias","year":"2012","unstructured":"Cruz-Tapias, P., Rojas-Villarraga, A., Maier-Moore, S. & Anaya, J. M. HLA and Sjogren\u2019s syndrome susceptibility. a meta-analysis of worldwide studies. Autoimmun. Rev. 11, 281\u2013287. https:\/\/doi.org\/10.1016\/j.autrev.2011.10.002 (2012).","journal-title":"Autoimmun. Rev."},{"key":"13042_CR57","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1136\/jnnp-2019-322115","volume":"91","author":"X Sun","year":"2020","unstructured":"Sun, X. et al. Myelin oligodendrocyte glycoprotein-associated disorders are associated with HLA subtypes in a Chinese paediatric-onset cohort. J. Neurol. Neurosurg. Psychiatry 91, 733\u2013739. https:\/\/doi.org\/10.1136\/jnnp-2019-322115 (2020).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"13042_CR58","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/569728","volume":"2012","author":"P Cruz-Tapias","year":"2012","unstructured":"Cruz-Tapias, P. et al. Shared HLA class II in Six autoimmune diseases in Latin America: a meta-analysis. Autoimmun. Dis. 2012, 569728. https:\/\/doi.org\/10.1155\/2012\/569728 (2012).","journal-title":"Autoimmun. Dis."},{"key":"13042_CR59","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1155\/2015\/948723","volume":"948723\u2013948723","author":"A Bettencourt","year":"2015","unstructured":"Bettencourt, A. et al. The protective role of HLA-DRB1(\u2217)13 in autoimmune diseases. J. Immunol. Res. 948723\u2013948723, 2015. https:\/\/doi.org\/10.1155\/2015\/948723 (2015).","journal-title":"J. Immunol. Res."},{"key":"13042_CR60","doi-asserted-by":"publisher","first-page":"453","DOI":"10.2174\/138920207783591690","volume":"8","author":"SCL Gough","year":"2007","unstructured":"Gough, S. C. L. & Simmonds, M. J. The HLA region and autoimmune disease: associations and mechanisms of action. Curr. Genom. 8, 453\u2013465. https:\/\/doi.org\/10.2174\/138920207783591690 (2007).","journal-title":"Curr. Genom."},{"key":"13042_CR61","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.autrev.2011.03.003","volume":"10","author":"Q Zhang","year":"2011","unstructured":"Zhang, Q., Lin, C. Y., Dong, Q., Wang, J. & Wang, W. Relationship between HLA-DRB1 polymorphism and susceptibility or resistance to multiple sclerosis in Caucasians: a meta-analysis of non-family-based studies. Autoimmun. Rev. 10, 474\u2013481. https:\/\/doi.org\/10.1016\/j.autrev.2011.03.003 (2011).","journal-title":"Autoimmun. Rev."},{"key":"13042_CR62","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41598-020-80535-3","volume":"11","author":"MP Alvarenga","year":"2021","unstructured":"Alvarenga, M. P. et al. Neuromyelitis optica is an HLA associated disease different from multiple sclerosis: a systematic review with meta-analysis. Sci. Rep. 11, 152. https:\/\/doi.org\/10.1038\/s41598-020-80535-3 (2021).","journal-title":"Sci. Rep."},{"key":"13042_CR63","unstructured":"Hachicha, H. et al. HLA-DRB1*03 is associated with systemic lupus erythematosus and anti -SSB production in South Tunisia. Int. J. Health Sci. 12 (2018)."},{"key":"13042_CR64","doi-asserted-by":"publisher","first-page":"3394","DOI":"10.1210\/jcem.83.10.5137","volume":"83","author":"JM Heward","year":"1998","unstructured":"Heward, J. M. et al. Linkage disequilibrium between the human leukocyte antigen class II region of the major histocompatibility complex and graves\u2019 disease: replication using a population case control and family-based study1. J. Clin. Endocrinol. Metab. 83, 3394\u20133397. https:\/\/doi.org\/10.1210\/jcem.83.10.5137 (1998).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"13042_CR65","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1186\/1471-2474-14-307","volume":"14","author":"M Yang","year":"2013","unstructured":"Yang, M. et al. Meta-analysis of the association of HLA-DRB1 with rheumatoid arthritis in Chinese populations. BMC Musculoskelet. Disord. 14, 307\u2013307. https:\/\/doi.org\/10.1186\/1471-2474-14-307 (2013).","journal-title":"BMC Musculoskelet. Disord."},{"key":"13042_CR66","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.autrev.2012.02.002","volume":"11","author":"J-M Anaya","year":"2012","unstructured":"Anaya, J.-M. Common mechanisms of autoimmune diseases (the autoimmune tautology). Autoimmun. Rev. 11, 781\u2013784. https:\/\/doi.org\/10.1016\/j.autrev.2012.02.002 (2012).","journal-title":"Autoimmun. Rev."},{"key":"13042_CR67","doi-asserted-by":"publisher","first-page":"984","DOI":"10.3389\/fimmu.2017.00984","volume":"8","author":"EM Scholz","year":"2017","unstructured":"Scholz, E. M. et al. Human Leukocyte Antigen (HLA)-DRB1*15:01 and HLA-DRB5*01:01 Present Complementary Peptide Repertoires. Front. Immunol. 8, 984. https:\/\/doi.org\/10.3389\/fimmu.2017.00984 (2017).","journal-title":"Front. Immunol."},{"key":"13042_CR68","doi-asserted-by":"publisher","first-page":"13659","DOI":"10.1073\/pnas.2003170117","volume":"117","author":"NN Logunova","year":"2020","unstructured":"Logunova, N. N. et al. MHC-II alleles shape the CDR3 repertoires of conventional and regulatory naive CD4(+) T cells. Proc. Natl. Acad. Sci. U. S. A. 117, 13659\u201313669. https:\/\/doi.org\/10.1073\/pnas.2003170117 (2020).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"13042_CR69","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.3324\/haematol.2017.179119","volume":"103","author":"J Hrdinova","year":"2018","unstructured":"Hrdinova, J. et al. Mass spectrometry-assisted identification of ADAMTS13-derived peptides presented on HLA-DR and HLA-DQ. Haematologica 103, 1083\u20131092. https:\/\/doi.org\/10.3324\/haematol.2017.179119 (2018).","journal-title":"Haematologica"},{"key":"13042_CR70","doi-asserted-by":"publisher","first-page":"11486","DOI":"10.1074\/jbc.RA120.014016","volume":"295","author":"CH Coles","year":"2020","unstructured":"Coles, C. H. et al. T cell receptor interactions with human leukocyte antigen govern indirect peptide selectivity for the cancer testis antigen MAGE-A4. J. Biol. Chem. 295, 11486\u201311494. https:\/\/doi.org\/10.1074\/jbc.RA120.014016 (2020).","journal-title":"J. Biol. Chem."},{"key":"13042_CR71","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.707217","volume":"12","author":"M Houtman","year":"2021","unstructured":"Houtman, M. et al. Haplotype-specific expression analysis of MHC class II genes in healthy individuals and rheumatoid arthritis patients. Front. Immunol. 12, 707217. https:\/\/doi.org\/10.3389\/fimmu.2021.707217 (2021).","journal-title":"Front. Immunol."},{"key":"13042_CR72","doi-asserted-by":"publisher","first-page":"e14","DOI":"10.1016\/S2665-9913(19)30006-2","volume":"1","author":"C Terao","year":"2019","unstructured":"Terao, C. et al. IgG4-related disease in the Japanese population: a genome-wide association study. Lancet Rheumatol. 1, e14\u2013e22. https:\/\/doi.org\/10.1016\/S2665-9913(19)30006-2 (2019).","journal-title":"Lancet Rheumatol."},{"key":"13042_CR73","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1093\/bfgp\/elp010","volume":"8","author":"C Vandiedonck","year":"2009","unstructured":"Vandiedonck, C. & Knight, J. C. The human Major Histocompatibility Complex as a paradigm in genomics research. Brief Funct. Genomic Proteomic 8, 379\u2013394. https:\/\/doi.org\/10.1093\/bfgp\/elp010 (2009).","journal-title":"Brief Funct. Genomic Proteomic"},{"key":"13042_CR74","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1080\/09629350310001619735","volume":"12","author":"JD Torzecka","year":"2003","unstructured":"Torzecka, J. D. et al. Tumour necrosis factor-alpha polymorphism as one of the complex inherited factors in pemphigus. Mediators Inflamm. 12, 303\u2013307. https:\/\/doi.org\/10.1080\/09629350310001619735 (2003).","journal-title":"Mediators Inflamm."},{"key":"13042_CR75","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1111\/bjd.17191","volume":"180","author":"SY Zhang","year":"2019","unstructured":"Zhang, S. Y. et al. Subtype-specific inherited predisposition to pemphigus in the Chinese population. Br. J. Dermatol. 180, 828\u2013835. https:\/\/doi.org\/10.1111\/bjd.17191 (2019).","journal-title":"Br. J. Dermatol."},{"key":"13042_CR76","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1159\/000018030","volume":"197","author":"CW Lee","year":"1998","unstructured":"Lee, C. W., Yang, H. Y., Kim, S. C., Jung, J. H. & Hwang, J. J. HLA class II allele associations in korean patients with pemphigus. Dermatology 197, 349\u2013352. https:\/\/doi.org\/10.1159\/000018030 (1998).","journal-title":"Dermatology"},{"key":"13042_CR77","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/1523-1747.ep12337585","volume":"109","author":"S Miyagawa","year":"1997","unstructured":"Miyagawa, S. et al. HLA-DRB1*04 and DRB1*14 alleles are associated with susceptibility to pemphigus among Japanese. J. Invest. Dermatol. 109, 615\u2013618. https:\/\/doi.org\/10.1111\/1523-1747.ep12337585 (1997).","journal-title":"J. Invest. Dermatol."},{"key":"13042_CR78","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/ene.12525","volume":"22","author":"AV Nikolic","year":"2015","unstructured":"Nikolic, A. V. et al. High frequency of DQB1*05 and absolute absence of DRB1*13 in muscle-specific tyrosine kinase positive myasthenia gravis. Eur. J. Neurol. 22, 59\u201363. https:\/\/doi.org\/10.1111\/ene.12525 (2015).","journal-title":"Eur. J. Neurol."},{"key":"13042_CR79","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/tan.12796","volume":"87","author":"D Zivanovic","year":"2016","unstructured":"Zivanovic, D., Bojic, S., Medenica, L., Andric, Z. & Popadic, D. Human leukocyte antigen class II (DRB1 and DQB1) alleles and haplotypes frequencies in patients with pemphigus vulgaris among the Serbian population. HLA 87, 367\u2013374. https:\/\/doi.org\/10.1111\/tan.12796 (2016).","journal-title":"HLA"},{"key":"13042_CR80","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.13298","author":"G Dere","year":"2020","unstructured":"Dere, G. et al. Assessment of HLA-A, HLA-DR, and HLA-DQ alleles in patients with pemphigus vulgaris from eastern of Turkey. J. Cosmet. Dermatol. https:\/\/doi.org\/10.1111\/jocd.13298 (2020).","journal-title":"J. Cosmet. Dermatol."},{"key":"13042_CR81","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.jns.2015.11.021","volume":"359","author":"S Ehsan","year":"2015","unstructured":"Ehsan, S. et al. Association of HLA class II (DRB1, DQA1, DQB1) alleles and haplotypes with myasthenia gravis and its subgroups in the Iranian population. J. Neurol. Sci. 359, 335\u2013342. https:\/\/doi.org\/10.1016\/j.jns.2015.11.021 (2015).","journal-title":"J. Neurol. Sci."},{"key":"13042_CR82","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1016\/j.humimm.2013.08.271","volume":"74","author":"M Alahgholi-Hajibehzad","year":"2013","unstructured":"Alahgholi-Hajibehzad, M. et al. Association of HLA-DRB1 *14, -DRB1 *16 and -DQB1 *05 with MuSK-myasthenia gravis in patients from Turkey. Hum. Immunol. 74, 1633\u20131635. https:\/\/doi.org\/10.1016\/j.humimm.2013.08.271 (2013).","journal-title":"Hum. Immunol."},{"key":"13042_CR83","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1111\/ijd.12184","volume":"53","author":"E Harfouch","year":"2014","unstructured":"Harfouch, E. & Daoud, S. Allelic variation in HLA-DRB1* loci in Syrian pemphigus vulgaris patients. Int. J. Dermatol. 53, 1460\u20131463. https:\/\/doi.org\/10.1111\/ijd.12184 (2014).","journal-title":"Int. J. Dermatol."},{"key":"13042_CR84","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/j.1399-0039.1998.tb03043.x","volume":"52","author":"MF Gonz\u00e1lez-Escribano","year":"1998","unstructured":"Gonz\u00e1lez-Escribano, M. F. et al. Distribution of HLA class II alleles among Spanish patients with pemphigus vulgaris. Tissue Antigens 52, 275\u2013278. https:\/\/doi.org\/10.1111\/j.1399-0039.1998.tb03043.x (1998).","journal-title":"Tissue Antigens"},{"key":"13042_CR85","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jaut.2016.04.007","volume":"72","author":"MJ Brochado","year":"2016","unstructured":"Brochado, M. J. et al. Differential HLA class I and class II associations in pemphigus foliaceus and pemphigus vulgaris patients from a prevalent Southeastern Brazilian region. J. Autoimmun. 72, 19\u201324. https:\/\/doi.org\/10.1016\/j.jaut.2016.04.007 (2016).","journal-title":"J. Autoimmun."},{"key":"13042_CR86","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/sj.gene.6363839","volume":"3","author":"P Martel","year":"2002","unstructured":"Martel, P. et al. Epistasis between DSG1 and HLA class II genes in pemphigus foliaceus. Genes Immun. 3, 205\u2013210. https:\/\/doi.org\/10.1038\/sj.gene.6363839 (2002).","journal-title":"Genes Immun."},{"key":"13042_CR87","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/iji.12052","volume":"40","author":"Z P\u00e1rnick\u00e1","year":"2013","unstructured":"P\u00e1rnick\u00e1, Z., \u0160vecov\u00e1, D., Javor, J., Shawkatov\u00e1, I. & Buc, M. High susceptibility to pemphigus vulgaris due to HLA-DRB1*14:54 in the Slovak population. Int. J. Immunogenet. 40, 471\u2013475. https:\/\/doi.org\/10.1111\/iji.12052 (2013).","journal-title":"Int. J. Immunogenet."},{"key":"13042_CR88","doi-asserted-by":"publisher","first-page":"e212","DOI":"10.1111\/bjd.16022","volume":"178","author":"L de Sena Nogueira Maehara","year":"2018","unstructured":"de Sena Nogueira Maehara, L. et al. HLA class II alleles of susceptibility and protection in Brazilian and Dutch pemphigus foliaceus. Br. J. Dermatol. 178, e212\u2013e214. https:\/\/doi.org\/10.1111\/bjd.16022 (2018).","journal-title":"Br. J. Dermatol."},{"key":"13042_CR89","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1111\/j.1538-7836.2010.03772.x","volume":"8","author":"P Coppo","year":"2010","unstructured":"Coppo, P. et al. HLA-DRB1*11: a strong risk factor for acquired severe ADAMTS13 deficiency-related idiopathic thrombotic thrombocytopenic purpura in Caucasians. J. Thromb. Haemost. 8, 856\u2013859. https:\/\/doi.org\/10.1111\/j.1538-7836.2010.03772.x (2010).","journal-title":"J. Thromb. Haemost."},{"key":"13042_CR90","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jns.2016.02.031","volume":"363","author":"T Kanai","year":"2016","unstructured":"Kanai, T. et al. HLA-DRB1*14 and DQB1*05 are associated with Japanese anti-MuSK antibody-positive myasthenia gravis patients. J. Neurol. Sci. 363, 116\u2013118. https:\/\/doi.org\/10.1016\/j.jns.2016.02.031 (2016).","journal-title":"J. Neurol. Sci."},{"key":"13042_CR91","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2019.116533","volume":"407","author":"S Cotti Piccinelli","year":"2019","unstructured":"Cotti Piccinelli, S. et al. Human leukocyte antigens class II in CIDP spectrum neuropathies. J. Neurol. Sci. 407, 116533. https:\/\/doi.org\/10.1016\/j.jns.2019.116533 (2019).","journal-title":"J. Neurol. Sci."},{"key":"13042_CR92","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1111\/ced.13774","volume":"44","author":"M Saha","year":"2019","unstructured":"Saha, M. et al. Sporadic pemphigus foliaceus and class II human leucocyte antigen allele associations in the white British and Indo-Asian populations in the UK. Clin. Exp. Dermatol. 44, 290\u2013294. https:\/\/doi.org\/10.1111\/ced.13774 (2019).","journal-title":"Clin. Exp. Dermatol."},{"key":"13042_CR93","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1111\/ijd.13577","volume":"56","author":"JM Gil","year":"2017","unstructured":"Gil, J. M. et al. Study of the association between human leukocyte antigens (HLA) and pemphigus vulgaris in Brazilian patients. Int. J. Dermatol. 56, 557\u2013562. https:\/\/doi.org\/10.1111\/ijd.13577 (2017).","journal-title":"Int. J. Dermatol."},{"key":"13042_CR94","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1111\/j.1365-2133.2009.09207.x","volume":"161","author":"O Abida","year":"2009","unstructured":"Abida, O. et al. Tunisian endemic pemphigus foliaceus is associated with the HLA-DR3 gene: anti-desmoglein 1 antibody-positive healthy subjects bear protective alleles. Br. J. Dermatol. 161, 522\u2013527. https:\/\/doi.org\/10.1111\/j.1365-2133.2009.09207.x (2009).","journal-title":"Br. J. Dermatol."},{"key":"13042_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2019.577139","volume":"339","author":"H Ogata","year":"2020","unstructured":"Ogata, H. et al. Unique HLA haplotype associations in IgG4 anti-neurofascin 155 antibody-positive chronic inflammatory demyelinating polyneuropathy. J. Neuroimmunol. 339, 577139. https:\/\/doi.org\/10.1016\/j.jneuroim.2019.577139 (2020).","journal-title":"J. Neuroimmunol."},{"key":"13042_CR96","doi-asserted-by":"publisher","first-page":"280","DOI":"10.4103\/ijdvl.IJDVL_1014_16","volume":"84","author":"A Priyadarshini","year":"2018","unstructured":"Priyadarshini, A., George, R., Daniel, D., Varughese, S. & Jayaseelan, V. Association between human leukocyte antigen-DRB1 and human leukocyte antigen-DQB1 alleles and pemphigus vulgaris in Indian patients: a case-control study. Indian J. Dermatol. Venereol. Leprol. 84, 280\u2013284. https:\/\/doi.org\/10.4103\/ijdvl.IJDVL_1014_16 (2018).","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"key":"13042_CR97","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/j.1346-8138.2009.00743.x","volume":"37","author":"M Tunca","year":"2010","unstructured":"Tunca, M., Musabak, U., Sagkan, R. I., Koc, E. & Akar, A. Association of human leukocyte antigen class II alleles with pemphigus vulgaris in a Turkish population. J. Dermatol. 37, 246\u2013250. https:\/\/doi.org\/10.1111\/j.1346-8138.2009.00743.x (2010).","journal-title":"J. Dermatol."},{"key":"13042_CR98","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/tan.12519","volume":"85","author":"O Haase","year":"2015","unstructured":"Haase, O. et al. Association with HLA-DRB1 in Egyptian and German pemphigus vulgaris patients. Tissue Antigens 85, 283\u2013286. https:\/\/doi.org\/10.1111\/tan.12519 (2015).","journal-title":"Tissue Antigens"},{"key":"13042_CR99","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s12974-017-0996-1","volume":"14","author":"L Martinez-Martinez","year":"2017","unstructured":"Martinez-Martinez, L. et al. Anti-NF155 chronic inflammatory demyelinating polyradiculoneuropathy strongly associates to HLA-DRB15. J. Neuroinflammation 14, 224. https:\/\/doi.org\/10.1186\/s12974-017-0996-1 (2017).","journal-title":"J. Neuroinflammation"},{"key":"13042_CR100","first-page":"28","volume":"59","author":"RR Glorio","year":"1999","unstructured":"Glorio, R. R. et al. Determinacion por PCR de la asociacion entre antigenos HLA clase II y penfigo vulgar. Med. (Buenos Aires) 59, 28\u201332 (1999).","journal-title":"Med. (Buenos Aires)"},{"key":"13042_CR101","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/sj.gene.6363939","volume":"4","author":"DP Pavoni","year":"2003","unstructured":"Pavoni, D. P., Roxo, V. M. M. S., Marquart Filho, A. & Petzl-Erler, M. L. Dissecting the associations of endemic Pemphigus Foliaceus (Fogo Selvagem) with HLA-DRB1 alleles and genotypes. Genes Immun. 4, 110\u2013116. https:\/\/doi.org\/10.1038\/sj.gene.6363939 (2003).","journal-title":"Genes Immun."},{"key":"13042_CR102","first-page":"531","volume":"89","author":"GJJ Thomas","year":"1998","unstructured":"Thomas, G. J. J., Conejo-Mir, J. S., Escribano, F. G., Bernal, A. M. P. & Rold\u00e1n, A. N. Estudio de los alelos de HLA de clase II que confieren susceptibilidad al p\u00e9nfigo vulgar en una poblaci\u00f3n andaluza. ACTAS Dermo-Sifiliograficas 89, 531\u2013538 (1998).","journal-title":"ACTAS Dermo-Sifiliograficas"},{"key":"13042_CR103","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1007\/BF00216698","volume":"33","author":"JR Moraes","year":"1991","unstructured":"Moraes, J. R. et al. HLA antigens and risk for development of pemphigus foliaceus (fogo selvagem) in endemic areas of Brazil. Immunogenetics 33, 388\u2013391. https:\/\/doi.org\/10.1007\/BF00216698 (1991).","journal-title":"Immunogenetics"},{"key":"13042_CR104","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s10875-008-9244-x","volume":"29","author":"S Shams","year":"2009","unstructured":"Shams, S. et al. HLA Class II (DRB, DQA1 and DQB1) allele and haplotype frequencies in the patients with pemphigus vulgaris. J. Clin. Immunol. 29, 175\u2013179. https:\/\/doi.org\/10.1007\/s10875-008-9244-x (2009).","journal-title":"J. Clin. Immunol."},{"key":"13042_CR105","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jdermsci.2014.08.006","volume":"76","author":"E Orouji","year":"2014","unstructured":"Orouji, E., Tavakkol Afshari, J., Schmieder, A. & Layegh, P. HLA-DQB1 gene and pemphigus vulgaris in patients with Mid-East origin. J. Dermatol. Sci. 76, 153\u2013155. https:\/\/doi.org\/10.1016\/j.jdermsci.2014.08.006 (2014).","journal-title":"J. Dermatol. Sci."},{"key":"13042_CR106","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.241968","author":"BS Joly","year":"2020","unstructured":"Joly, B. S. et al. HLA-DRB1*11 is a strong risk factor for acquired thrombotic thrombocytopenic purpura in children. Haematologica https:\/\/doi.org\/10.3324\/haematol.2019.241968 (2020).","journal-title":"Haematologica"},{"key":"13042_CR107","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1007\/s10227-001-0157-z","volume":"6","author":"R Glorio","year":"2002","unstructured":"Glorio, R. et al. HLA haplotypes and class II molecular alleles in argentinian patients with pemphigus vulgaris. JCMS 6, 422\u2013426. https:\/\/doi.org\/10.1007\/s10227-001-0157-z (2002).","journal-title":"JCMS"},{"key":"13042_CR108","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1182\/blood.2020005395","volume":"135","author":"K Sakai","year":"2020","unstructured":"Sakai, K. et al. HLA loci predisposing to immune TTP in Japanese: potential role of the shared ADAMTS13 peptide bound to different HLA-DR. Blood 135, 2413\u20132419. https:\/\/doi.org\/10.1182\/blood.2020005395 (2020).","journal-title":"Blood"},{"key":"13042_CR109","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1365-4632.2012.05541.x","volume":"52","author":"CK Koc","year":"2013","unstructured":"Koc, C. K., Sallakci, N., Akman-Karaka\u015f, A., Alpsoy, E. & Yegin, O. Human leukocyte antigens class I and class II in patients with pemphigus in southern Turkey. Int. J. Dermatol. 52, 53\u201358. https:\/\/doi.org\/10.1111\/j.1365-4632.2012.05541.x (2013).","journal-title":"Int. J. Dermatol."},{"key":"13042_CR110","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/j.1538-7836.2009.03692.x","volume":"8","author":"M Scully","year":"2010","unstructured":"Scully, M. et al. Human leukocyte antigen association in idiopathic thrombotic thrombocytopenic purpura: evidence for an immunogenetic link. J. Thromb. Haemost. 8, 257\u2013262. https:\/\/doi.org\/10.1111\/j.1538-7836.2009.03692.x (2010).","journal-title":"J. Thromb. Haemost."},{"key":"13042_CR111","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/S0198-8859(97)00182-1","volume":"57","author":"N Mobini","year":"1997","unstructured":"Mobini, N. et al. Identical MHC markers in non-jewish iranian and ashkenazi jewish patients with pemphigus vulgaris: possible common central asian ancestral origin. Hum. Immunol. 57, 62\u201367. https:\/\/doi.org\/10.1016\/S0198-8859(97)00182-1 (1997).","journal-title":"Hum. Immunol."},{"key":"13042_CR112","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/S0198-8859(97)00203-6","volume":"57","author":"JC Delgado","year":"1997","unstructured":"Delgado, J. C. et al. Pemphigus vulgaris autoantibody response is linked to HLA-DQB10503 in Pakistani Patients. Hum. Immunol. 57, 110\u2013119. https:\/\/doi.org\/10.1016\/S0198-8859(97)00203-6 (1997).","journal-title":"Hum. Immunol."},{"key":"13042_CR113","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/j.1399-0039.1998.tb03026.x","volume":"52","author":"Y Yamashina","year":"1998","unstructured":"Yamashina, Y. et al. Polymorphisms of HLA class II genes in Japanese patients with pemphigus vulgaris. Tissue Antigens 52, 74\u201377. https:\/\/doi.org\/10.1111\/j.1399-0039.1998.tb03026.x (1998).","journal-title":"Tissue Antigens"},{"key":"13042_CR114","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/j.lpm.2019.09.009","volume":"48","author":"C Al Haddad","year":"2019","unstructured":"Al Haddad, C., Finianos, P., Zgheib, E., Germanos, M. & Coppo, P. Risk factors associated with the human leucocyte antigen system in Lebanese patients with immune-mediated thrombotic thrombocytopenic purpura. La Presse M\u00e9dicale 48, 1182\u20131184. https:\/\/doi.org\/10.1016\/j.lpm.2019.09.009 (2019).","journal-title":"La Presse M\u00e9dicale"},{"key":"13042_CR115","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s00277-011-1384-z","volume":"91","author":"M-L John","year":"2012","unstructured":"John, M.-L., Hitzler, W. & Scharrer, I. The role of human leukocyte antigens as predisposing and\/or protective factors in patients with idiopathic thrombotic thrombocytopenic purpura. Ann. Hematol. 91, 507\u2013510. https:\/\/doi.org\/10.1007\/s00277-011-1384-z (2012).","journal-title":"Ann. Hematol."},{"key":"13042_CR116","doi-asserted-by":"publisher","first-page":"e0156679","DOI":"10.1371\/journal.pone.0156679","volume":"11","author":"S Martino","year":"2016","unstructured":"Martino, S. et al. Thrombotic thrombocytopenic purpura in black people: impact of ethnicity on survival and genetic risk factors. PLoS ONE 11, e0156679\u2013e0156679. https:\/\/doi.org\/10.1371\/journal.pone.0156679 (2016).","journal-title":"PLoS ONE"},{"key":"13042_CR117","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1111\/j.1399-0039.1993.tb02180.x","volume":"42","author":"M Cerna","year":"1993","unstructured":"Cerna, M. et al. Genetic markers for susceptibility to endemic Brazilian pemphigus foliaceus (Fogo Selvagem) in Xavante Indians. Tissue Antigens 42, 138\u2013140. https:\/\/doi.org\/10.1111\/j.1399-0039.1993.tb02180.x (1993).","journal-title":"Tissue Antigens"},{"key":"13042_CR118","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1046\/j.1365-4362.2002.01370.x","volume":"41","author":"A Birol","year":"2002","unstructured":"Birol, A., Anadolu, R. Y., Tutkak, H. & G\u00fcrgey, E. HLA-class 1 and class 2 antigens in Turkish patients with pemphigus. Int. J. Dermatol. 41, 79\u201383. https:\/\/doi.org\/10.1046\/j.1365-4362.2002.01370.x (2002).","journal-title":"Int. J. Dermatol."},{"key":"13042_CR119","first-page":"587","volume":"152","author":"L Rangel-Gamboa","year":"2016","unstructured":"Rangel-Gamboa, L., Vega-Memije, M. E., Acu\u00f1a-Alonzo, V. & Granados-Arriola, J. HLA class II in Mexican patients with pemphigus vulgaris: shared epitope for autoimmunity. Gac. Med. Mex. 152, 587\u2013591 (2016).","journal-title":"Gac. Med. Mex."},{"key":"13042_CR120","first-page":"233","volume":"25","author":"SW Khan","year":"2015","unstructured":"Khan, S. W., Iftikhar, N., Ahmed, T. A. & Bashir, M. HLA- DR alleles in pakistani patients of pemphigus vulgaris. J. Coll. Phys. Surg. Pak. 25, 233\u2013236 (2015).","journal-title":"J. Coll. Phys. Surg. Pak."},{"key":"13042_CR121","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1111\/j.1399-0039.1996.tb02689.x","volume":"48","author":"C Carcassi","year":"1996","unstructured":"Carcassi, C. et al. HLA haplotypes and class II molecular alleles in Sardinian and Italian patients with pemphigus vulgaris. Tissue Antigens 48, 662\u2013667. https:\/\/doi.org\/10.1111\/j.1399-0039.1996.tb02689.x (1996).","journal-title":"Tissue Antigens"},{"key":"13042_CR122","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1111\/j.1399-0039.1996.tb02545.x","volume":"47","author":"ML Lombardi","year":"1996","unstructured":"Lombardi, M. L. et al. Molecular analysis of HLA DRB1 and DQB1 in Italian patients with pemphigus vulgaris. Tissue Antigens 47, 228\u2013230. https:\/\/doi.org\/10.1111\/j.1399-0039.1996.tb02545.x (1996).","journal-title":"Tissue Antigens"},{"key":"13042_CR123","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/jid.2009.241","volume":"130","author":"M Saha","year":"2010","unstructured":"Saha, M. et al. Pemphigus Vulgaris in White Europeans Is Linked with HLA Class II Allele HLA DRB1*1454 but Not DRB1*1401. J. Investig. Dermatol. 130, 311\u2013314. https:\/\/doi.org\/10.1038\/jid.2009.241 (2010).","journal-title":"J. Investig. Dermatol."},{"key":"13042_CR124","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1212\/01.wnl.0000218159.79769.5c","volume":"66","author":"EH Niks","year":"2006","unstructured":"Niks, E. H. et al. Strong association of MuSK antibody-positive myasthenia gravis and HLA-DR14-DQ5. Neurology 66, 1772\u20131774. https:\/\/doi.org\/10.1212\/01.wnl.0000218159.79769.5c (2006).","journal-title":"Neurology"},{"key":"13042_CR125","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.humimm.2016.11.005","volume":"78","author":"G Sinkovits","year":"2017","unstructured":"Sinkovits, G. et al. The role of human leukocyte antigen DRB1-DQB1 haplotypes in the susceptibility to acquired idiopathic thrombotic thrombocytopenic purpura. Hum. Immunol. 78, 80\u201387. https:\/\/doi.org\/10.1016\/j.humimm.2016.11.005 (2017).","journal-title":"Hum. Immunol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-13042-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-13042-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-13042-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T21:15:41Z","timestamp":1675718141000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-13042-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,2]]},"references-count":125,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["13042"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-13042-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-638050\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-638050\/v2","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,2]]},"assertion":[{"value":"28 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9229"}}